AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 3 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,885,000 | -19.7% | 500,000 | 0.0% | 0.05% | -19.3% |
Q2 2023 | $4,840,000 | -53.7% | 500,000 | -47.6% | 0.06% | -59.9% |
Q1 2023 | $10,449,944 | +97.4% | 953,462 | -22.2% | 0.14% | +100.0% |
Q4 2022 | $5,293,957 | +211.2% | 1,225,453 | +624.2% | 0.07% | +173.1% |
Q2 2022 | $1,701,000 | – | 169,209 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |